These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9403571)

  • 1. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species.
    Gonick HC; Ding Y; Bondy SC; Ni Z; Vaziri ND
    Hypertension; 1997 Dec; 30(6):1487-92. PubMed ID: 9403571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase expression in the course of lead-induced hypertension.
    Vaziri ND; Ding Y; Ni Z
    Hypertension; 1999 Oct; 34(4 Pt 1):558-62. PubMed ID: 10523326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension.
    Ni Z; Bemanian S; Kivlighn SD; Vaziri ND
    Kidney Int; 1998 Jul; 54(1):188-92. PubMed ID: 9648078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug.
    Vaziri ND; Ding Y; Ni Z
    J Pharmacol Exp Ther; 2001 Aug; 298(2):679-85. PubMed ID: 11454931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression.
    Alexander BT; Cockrell KL; Massey MB; Bennett WA; Granger JP
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):170-5. PubMed ID: 11863253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical increase in nitric oxide synthase activity in hypercholesterolaemic rats with impaired renal function and decreased activity of nitric oxide.
    Rahman MM; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 2001 Feb; 16(2):262-8. PubMed ID: 11158398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy.
    Vaziri ND; Ding Y; Ni Z; Gonick HC
    Kidney Int; 1997 Oct; 52(4):1042-6. PubMed ID: 9328943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leptin stimulates systemic nitric oxide production in the rat.
    Beltowski J; Wójcicka G; Borkowska E
    Obes Res; 2002 Sep; 10(9):939-46. PubMed ID: 12226143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat.
    Wen C; Li M; Fraser T; Wang J; Turner SW; Whitworth JA
    Blood Press; 2000; 9(5):298-304. PubMed ID: 11193135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
    Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1.
    Edwards DL; Arora CP; Bui DT; Castro LC
    Am J Obstet Gynecol; 1996 Aug; 175(2):484-8. PubMed ID: 8765273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats.
    Vaziri ND; Ni Z; Oveisi F
    Hypertension; 1998 Jun; 31(6):1248-54. PubMed ID: 9622137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead-induced hypertension: possible role of endothelial factors.
    Khalil-Manesh F; Gonick HC; Weiler EW; Prins B; Weber MA; Purdy RE
    Am J Hypertens; 1993 Sep; 6(9):723-9. PubMed ID: 8110424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine.
    Rahman MM; Varghese Z; Fuller BJ; Moorhead JF
    Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels.
    Dursun N; Arifoglu C; Süer C; Keskinol L
    Biol Trace Elem Res; 2005 May; 104(2):141-9. PubMed ID: 15894814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside.
    Ding Y; Vaziri ND; Gonick HC
    Environ Res; 1998 Feb; 76(2):107-13. PubMed ID: 9515065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension.
    Vaziri ND; Liang K; Ding Y
    Kidney Int; 1999 Oct; 56(4):1492-8. PubMed ID: 10504500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
    Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
    Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia.
    Beltowski J; Wójcicka G; Jamroz-Wiśniewska A; Borkowska E; Marciniak A
    Life Sci; 2005 Aug; 77(15):1855-68. PubMed ID: 15913657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension.
    Kang DG; Hur TY; Lee GM; Oh H; Kwon TO; Sohn EJ; Lee HS
    Life Sci; 2002 Apr; 70(22):2599-609. PubMed ID: 12269387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.